Abstract

Cancer Biomarkers: A Market Landscape and Publication Trends Analysis

Enal Razvi, Managing Director, Select Biosciences Inc

This presentation frames the broader market landscape for cancer biomarkers evaluated utilizing a number of industry metrics. We have utilized computational approaches to analyze the full cancer biomarkers publications space and this allows us to visualize publications trends as well as identify associations of specific molecular entities with various disease classes. We have performed an extensive analysis of the cancer biomarkers field and have found specific patterns of association with breast cancer for instance. This analysis is scalable as it is applicable to various classes and can be utilized as a means to predict biomarker associations which can then be experimentally-validated using retrospectively- or prospectively-isolated clinical samples. We also compare in this analysis traditional biomarkers (protein-based) with nucleic acid-based biomarkers arising from genomics-based discovery projects.